![Newsletter](https://res.cloudinary.com/dvadu7nre/image/fetch/https://sterlingaccuris.com/static-assets/sterlingaccurislabassistant.webp)
![Go Back](/static-assets/image/black-back-icon.png)
Help Center
Zygomycosis primarily affects immunosuppressed and diabetic patients. It is increasingly seen in transplant recipients, hematologic malignancy patients, and those with Covid-19 complications. Clinical signs include skin induration, erythema, and necrosis. Diagnosis involves histological examination, culture, and treatment consisting of surgery, addressing risk factors, and antifungal medications.
![Newsletter](https://res.cloudinary.com/dvadu7nre/image/fetch/https://sterlingaccuris.com/static-assets/sterlingaccurislabassistant.webp)